Assessing market opportunity with a holistic, multi-pronged approach
Client had a new asset with potential to be the first therapy approved in an indication that had no available treatments prior to a transplant. To develop an informed and solid global commercial launch strategy, the team needed to inform and update current inputs to the demand forecast and identify new inputs and assumptions to further refine the forecast. Simultaneously, there was a need to understand competitor impact and perceptions of future therapies entering the market.